Feb 22, 2019
If you are raising capital now, the path you are about to embark on can be stressful and littered with obstacles, but the light at the end of the tunnel is worth the trials and tribulations. Despite the inherent challenges of fundraising, the current climate is quite...
Feb 7, 2019
Join Geoff Meyerson, Locust Walk’s CEO & Co-Founder, in a fireside chat moderated by Sapna Srivastava, PhD, Chief Financial Officer and Chief Strategy Officer at Abide Therapeutics on February 11th from 12-12:55 pm at the BIO CEO & Investor Conference...
Feb 4, 2019
Locust Walk is a global life sciences transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Feb 4, 2019
Locust Walk is a global life science transaction firm. Our integrated team-based approach across capabilities, geographies, and industry segments delivers the right products, the right partners, and the most attractive sources of capital to get the right deals done...
Jan 17, 2019
Chris Ehrlich (Kellogg ’98), Managing Director, Global Head of Biopharma at Locust Walk leads emerging biotechnology and biopharma transactions, and will present at Kellogg School of Management on January 17th, 2019. Click here for more information.
